Related Experiment Videos
Transient riboflavin depletion in preterm infants
Archives of Disease in Childhood
|September 1, 1984
Summary
Preterm infants fed human milk are at risk for riboflavin deficiency. Early multivitamin or formula supplementation prevents deficiency, highlighting the importance of adequate riboflavin intake for infant health.
Area of Science:
- Neonatal Nutrition
- Biochemistry
- Pediatrics
Background:
- Preterm infants have unique nutritional needs.
- Riboflavin (vitamin B2) is essential for infant development.
- Human milk may have insufficient riboflavin for preterm infants.
Purpose of the Study:
- To assess riboflavin status in preterm infants on different diets.
- To determine the impact of multivitamin supplementation timing on riboflavin levels.
- To compare riboflavin status between human milk and preterm formula groups.
Main Methods:
- Biochemical riboflavin status was measured in 68 preterm infants.
- Infants received either human milk or preterm infant formula.
- Multivitamin supplementation timing (before or after day 7) was analyzed.
Main Results:
- Infants receiving multivitamins by day 7 showed no significant deficiency, regardless of diet.
- Infants on human milk supplemented after day 7 frequently developed abnormal riboflavin status (18/23).
- Formula-fed infants supplemented after day 7 had a significantly lower incidence of deficiency.
Conclusions:
- Human milk's riboflavin content may be insufficient for preterm infants, potentially reduced by photodegradation.
- Preterm infant formula or early multivitamin supplementation effectively prevents riboflavin deficiency.
- Routine riboflavin supplementation for preterm infants warrants consideration for safety and efficacy.